Summary: The Centers for Medicare & Medicaid Services modified its therapeutic embolization coverage policy, effective May 15, 2026. Here's what billing teams need to know before that date.
CMS therapeutic embolization coverage policy updates affect interventional radiology, vascular surgery, and interventional oncology practices billing embolization procedures under Medicare. The policy does not list specific CPT or HCPCS codes in the available data—more on that below. If your practice bills therapeutic embolization, review your claims processes now, well before the May 15, 2026 effective date.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Therapeutic Embolization |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Interventional Radiology, Vascular Surgery, Interventional Oncology, Neurovascular Surgery |
| Key Action | Audit therapeutic embolization claims against updated coverage criteria before May 15, 2026 |
CMS Therapeutic Embolization Coverage Criteria and Medical Necessity Requirements 2026
The real issue with any CMS policy modification to therapeutic embolization is medical necessity documentation. Therapeutic embolization is not a simple, uniform procedure—it spans liver tumor embolization, uterine fibroid embolization (UFE), arteriovenous malformation (AVM) treatment, hemorrhage control, and more. Each indication carries its own documentation burden, and CMS scrutinizes all of them.
When CMS modifies a coverage policy like this one, the change typically affects one or more of these elements: which clinical indications qualify as covered, what prior authorization requirements apply, what imaging or diagnostic workup must be documented before the procedure, or how the procedure is categorized for reimbursement purposes.
Therapeutic embolization billing under Medicare requires that your documentation prove the procedure was medically necessary for the specific patient, the specific indication, at the specific time it was performed. That's the baseline. Any modification to this coverage policy likely tightens—or clarifies—what "medically necessary" means in this context.
Because the policy source data available at this time does not include the full text of the modified criteria, your billing team should pull the complete policy from the CMS coverage database and compare it line by line against your current internal billing guidelines. If your practice uses a Medicare Administrative Contractor (MAC) local coverage determination (LCD) for therapeutic embolization, check whether your MAC has issued a corresponding update. MAC-level LCDs frequently follow national policy changes, sometimes with additional regional criteria.
Prior authorization for therapeutic embolization varies by Medicare Advantage plan and by MAC jurisdiction. The CMS modification effective May 15, 2026 may introduce new prior auth requirements or modify existing ones. Do not assume your current prior authorization workflow is still correct after that date.
CMS Therapeutic Embolization Exclusions and Non-Covered Indications
This is where therapeutic embolization billing gets complicated. CMS has historically drawn clear lines between covered and non-covered embolization indications—and those lines shift when a policy is modified.
Procedures considered investigational or not meeting medical necessity criteria under Medicare get denied on claim submission. That's not a warning—it's a pattern that billing teams in interventional radiology see regularly.
Common exclusion categories for embolization procedures under CMS coverage policy have historically included: embolization for indications lacking sufficient clinical evidence, procedures performed when less invasive alternatives were not first attempted, and cases where documentation of the clinical workup is incomplete. If the May 15, 2026 modification changes any of these exclusion criteria, your denial rate will shift accordingly—in either direction.
Talk to your compliance officer before the effective date. If you're billing a mix of indications—oncologic, vascular, gynecologic—you need to know exactly which ones the updated policy covers and which ones require additional documentation or carry claim denial risk.
Coverage Indications at a Glance
The policy data available for this modification does not include a detailed, indication-level breakdown from the source document. The table below reflects what is typically included in CMS therapeutic embolization coverage policy—use this as a framework, but verify each row against the full published policy text before May 15, 2026.
| Indication | Status | Notes |
|---|---|---|
| Hepatic tumor embolization (hepatocellular carcinoma, metastatic liver disease) | Verify against updated policy | Medical necessity documentation required; imaging workup expected |
| Uterine fibroid embolization (UFE) | Verify against updated policy | Prior auth requirements vary by Medicare Advantage plan |
| Arteriovenous malformation (AVM) embolization | Verify against updated policy | May be covered as standalone or pre-surgical procedure; coding varies |
| Hemorrhage control (traumatic or post-surgical) | Verify against updated policy | Emergency context affects documentation requirements |
| Prostate artery embolization (PAE) | Verify against updated policy | Historically classified as investigational under some MAC LCDs |
| Bronchial artery embolization | Verify against updated policy | Indication-specific documentation required |
Do not rely on this table as a final coverage determination. Pull the full updated policy text from CMS and confirm each indication's status under the modified coverage policy before billing after May 15, 2026.
CMS Therapeutic Embolization Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Pull the full updated policy text now. The effective date is May 15, 2026. You have time to review the changes carefully before they affect your claims. Access the policy at the CMS coverage database or through your MAC's website. Compare it to the version your billing team currently uses. |
| 2 | Check your MAC's LCD for corresponding updates. National CMS policy changes often trigger MAC-level LCD revisions. Contact your Medicare Administrative Contractor or check their website for any companion local coverage determination updates tied to this modification. If your MAC has issued a revised LCD, your billing team needs to reconcile it with the national policy. |
| 3 | Audit your current therapeutic embolization claims against the updated medical necessity criteria. Look at the last 90 days of claims. Identify which indications you're billing most frequently. Match them against the updated coverage criteria line by line. If any indication's coverage status has changed, flag it immediately. |
| 4 | Update your charge capture and documentation templates before May 15, 2026. If the updated policy requires new or different documentation elements to support medical necessity, your clinical documentation must reflect that before the effective date. Don't update billing after the fact—update the intake and documentation process at the point of care. |
| 5 | Verify prior authorization workflows with each Medicare Advantage plan you contract with. MA plans follow CMS policy changes but often add their own prior auth layers. Contact your top five Medicare Advantage payers and confirm whether their prior authorization requirements for therapeutic embolization have changed in response to this CMS modification. |
| 6 | Train your interventional radiology and vascular surgery teams on what's changed. Billing denials for therapeutic embolization often trace back to clinical documentation gaps, not billing errors. Your physicians and procedure note templates need to reflect the updated coverage criteria. A brief team huddle before May 15, 2026 is worth more than a stack of denied claims in June. |
| 7 | Set a denial tracking flag for therapeutic embolization claims starting May 15, 2026. Track denial reason codes for the first 30 days after the effective date. If you see a spike in denials for a specific indication or documentation deficiency, you'll catch it early enough to appeal and correct your process. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Therapeutic Embolization Under This Policy
The policy data available for this modification does not include a specific list of CPT, HCPCS, or ICD-10 codes. This is not unusual for a CMS policy modification at this stage—full code tables often appear in the final published policy document rather than in interim notices.
Do not invent or assume codes based on this post. Therapeutic embolization billing covers a wide range of CPT codes depending on the approach, site, and clinical context—and assigning the wrong code is a faster path to a claim denial than almost any other error.
What to Do Instead
Pull the full policy text directly from the CMS coverage database. The published policy will list the exact CPT and HCPCS codes it governs. Cross-reference those codes against your current charge description master (CDM) and charge capture tools before May 15, 2026.
If your practice has a billing consultant or uses a coding reference service, send them the full published policy and ask for a code-level impact assessment. That's the right move here—especially given the breadth of procedures that fall under the therapeutic embolization umbrella.
Once the full code list is available, PayerPolicy will update this post with the complete CPT, HCPCS, and ICD-10 code tables. Check back at app.payerpolicy.org/p/cms/52-v1. above for the most current version.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.